☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Interview: Adagio Therapeutics' Tillman Gerngross Shares Insight on the Development of Antibodies to Prevent COVID-19
March 1, 2021
Oncopeptides' Pepaxto (melphalan flufenamide) Receives the US FDA's Approval for Triple Class Refractory Multiple Myeloma
March 1, 2021
PharmaShots Interview: Tetra Therapeutics' Mark Gurney Shares Insight on Topline Results of BPN14770 for Fragile X Syndrome
March 1, 2021
Formycon and Bioeq Confirms BLA Submission Strategy and Timeline for FYB201 (biosimilar- ranibizumab)
March 1, 2021
BridgeBio and Origin's Nulibry (fosdenopterin) Receives the US FDA's Approval as the First Therapy to Reduce the Risk of Mortality...
March 1, 2021
Roivant to Acquire Silicon Therapeutics for ~$450M
March 1, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions